Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Boehringer Ingelheim
Merck
AstraZeneca
Express Scripts

Last Updated: December 9, 2021

DrugPatentWatch Database Preview

Claims for Patent: 7,537,795

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 7,537,795
Title:Transdermal drug delivery devices having coated microprotrusions
Abstract: A device (12) and method are provided for percutaneous transdermal delivery of a potent pharmacologically active agent. The agent is dissolved in water to form an aqueous coating solution having an appropriate viscosity for coating extremely tiny skin piercing elements (10). The coating solution is applied to the skin piercing elements (10) using known coating techniques and then dried. The device (12) is applied to the skin of a living animal (e.g., a human), causing the microprotrusions (10) to pierce the stratum corneum and deliver a therapeutically effect dose of the agent to the animal.
Inventor(s): Cormier; Michel J. N. (Mountain View, CA), Young; Wendy A. (San Jose, CA), Nyam; Kofi (Palo Alto, CA), Daddona; Peter E. (Menlo Park, CA)
Assignee: Alza Corporation (Mountain View, CA)
Application Number:10/045,842
Patent Claims:1. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising: providing a member having a plurality of stratum corneum-piercing microprotrusions; applying an aqueous solution of the pharmacologically active agent onto the member; and drying said applied aqueous solution to form a dry agent-containing coating on said member, said coating being less than a thickness of the microprotrusions; wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25.degree. C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25.degree. C. less than about 500 centipoises; and wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

2. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising: providing a member having a plurality of stratum corneum-piercing microprotrusions; applying an aqueous solution of the pharmacologically active agent onto said microprotrusions; and drying said applied aqueous solution to form a dry agent-containing coating on said microprotrusions, said coating being less than a thickness of the microprotrusions; wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25.degree. C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25.degree. C. less than about 500 centipoises; and wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

3. The method of claim 2, wherein the coating provides systemic delivery of about 25% to 50% of the agent upon application of the device to the skin of a subject for 5 seconds and wherein the agent comprises desmopressin or hGH.

4. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising: providing a member having a plurality of stratum corneum-piercing microprotrusions; said microprotrusions adapted to pierce through the stratum corneum to a depth of less than about 500 micrometers; applying an aqueous solution of the pharmacologically active agent onto the member; and drying said applied aqueous solution to form a dry agent-containing coating on said member, said coating being less than a thickness of the microprotrusions; wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25.degree. C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25.degree. C. less than about 500 centipoises; and wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

5. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising: providing a member having a plurality of stratum corneum-piercing microprotrusions, said microprotrusions having a length of less than 500 micrometers and a thickness of less than 25 micrometers; applying an aqueous solution of the pharmacologically active agent onto the member; and drying said applied aqueous solution to form a dry agent-containing coating on said member, said coating being less than a thickness of the microprotrusions; wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25.degree. C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25.degree. C. less than about 500 centipoises; and wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

6. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising: providing a member having a plurality of stratum corneum-piercing microprotrusions; applying an aqueous solution of the pharmacologically active agent onto the member; said pharmacologically active agent selected from the group consisting of adrenocorticotropic hormone (ACTH (1-24)), calcitonin, desmopressin, leutinizing hormone releasing hormone (LHRH), goserelin, leuprolide, buserelin, triptorelin, parathyroid hormone (PTH), vasopressin, deamino [Val4, D-Arg8] arginine vasopressin, interferon alpha, interferon beta, interferon gamma, follicle stimulating hormone (FSH), erythoropoietin (EPO), granulocyte macrophage colony stimulating factor (GM-CSF), granulocyte colony stimulating factor (G-CSF), interleukin-10 (IL-10), glucagon, and growth regulatory factor (GRF); and drying said applied aqueous solution to form a dry agent-containing coating on said member, said coating being less than a thickness of the microprotrusions; wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25.degree. C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25.degree. C. less than about 500 centipoises; and wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

7. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising: providing a member having a plurality of stratum corneum-piercing microprotrusions; applying an aqueous solution of the pharmacologically active agent desmopressin onto the member; and drying said applied aqueous solution to form a dry agent-containing coating on said member, said coating being less than a thickness of the microprotrusions; wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25.degree. C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25.degree. C. less than about 500 centipoises; and wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

8. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising: providing a member having a plurality of stratus corneum-piercing microprotrusions; applying an aqueous solution of the pharmacologically active agent onto the member; and drying said applied aqueous solution to form a dry agent-containing coating on said member, said coating being less than a thickness of the microprotrusions; wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25.degree. C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25.degree. C. less than about 500 centipoises; and wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

9. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising: providing a member having a plurality of stratum corneum-piercing microprotrusions; applying an aqueous solution of the pharmacologically active agent onto the member; and drying said applied aqueous solution to form a dry agent-containing coating on said member, said coating being less than a thickness of the microprotrusions; wherein said agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25.degree. C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25.degree. C. less than about 50 centipoises; and wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

10. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising: providing a member having a plurality of stratum corneum-piercing microprotrusions; applying an aqueous solution of the pharmacologically active agent onto the member; and drying said applied aqueous solution to form a dry agent-containing coating on said member; said coating having a thickness over a surface of said member of less than 50 micrometers; wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25.degree. C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25.degree. C. less than about 500 centipoises; and wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

11. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising: providing a member having a plurality of stratum corneum-piercing microprotrusions; applying an aqueous solution of the pharmacologically active agent onto the member; and drying said applied aqueous solution to form a dry agent-containing coating on said member; said coating having a thickness over a surface of said member of less than 25 micrometers; wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25.degree. C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25.degree. C. less than about 500 centipoises; and wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

12. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising: providing a member having a plurality of stratum corneum-piercing microprotrusions; providing an aqueous solution comprising said pharmacologically active agent and an adjuvant; applying said aqueous solution onto the member; and drying said applied aqueous solution to form a dry agent-containing and adjuvant-containing coating on said member, said coating being less than a thickness of the microprotrusions; wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25.degree. C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25.degree. C. less than about 500 centipoises; and wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

13. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising: providing a member having a plurality of stratum corneum-piercing microprotrusions; applying an aqueous solution of the pharmacologically active agent onto the member; and drying said applied aqueous solution to form a dry agent-containing coating on said member; said coating comprising a loading of said pharmacologically active agent of less than 1 mg/cm.sup.2 of area of said member, and said coating being less than a thickness of the microprotrusions; wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25.degree. C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25.degree. C. less than about 500 centipoises; and wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

14. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising: providing a member having a plurality of stratum corneum-piercing microprotrusions; applying an aqueous solution of the pharmacologically active agent onto the member; and drying said applied aqueous solution to form a dry agent-containing coating on said member; said coating comprising a loading of said pharmacologically active agent of less than 0.5 mg/cm.sup.2 of area of said member, and said coating being less than a thickness of the microprotrusions; wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25.degree. C. of greater than about 50 mg/ml and said agent having an aqueous solution having a viscosity at about 25.degree. C. less than about 500 centipoises; and wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

15. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising: providing a member having a plurality of stratum corneum-piercing microprotrusions; applying an aqueous solution of the pharmacologically active agent onto said member by dip coating said member in said solution; and drying said applied aqueous solution to form a dry agent-containing coating on said member, said coating being less than a thickness of the microprotrusions; wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1mg, said agent having an aqueous solubility at about 25.degree. C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25.degree. C. of less than about 500 centipoises; and wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Baxter
Harvard Business School
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.